Photo by bermixstudio from unsplash
Retinal vein occlusion (RVO) is one of the most prevalent causes of visual loss in the Western World. Its pathogenesis is still not completely known. Chronic macular edema and ischemia… Click to show full abstract
Retinal vein occlusion (RVO) is one of the most prevalent causes of visual loss in the Western World. Its pathogenesis is still not completely known. Chronic macular edema and ischemia compromise the functional and anatomical status of the retina. Antivascular endothelial growth factor (anti-VEGF) injections have demonstrated better results than other previous options including observation or laser therapy. This narrative review aims to analyze the current aspects related to these drugs.
Keywords:
anti vegf;
retinal vein;
vegf drugs;
use anti;
drugs retinal
Journal Title: Current drug targets
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Current drug targets
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!